Blair William & CO Invitae Corp Transaction History

Blair William & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $160,421 - $221,726	-6,599 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $31,308 - $48,480	-1,200 Reduced 15.39%	6,599 $223,000
Q1 2021 May 13, 2021	BUY	$33.06 - $56.93 $257,834 - $443,997	7,799 New	7,799 $298,000
Q4 2020 Feb 09, 2021	SELL	$39.09 - $57.4 $185,677 - $272,650	-4,750 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$28.43 - $44.67 $135,042 - $212,182	4,750 New	4,750 $206,000
Q2 2020 Aug 12, 2020	SELL	$11.71 - $30.29 $125,355 - $324,254	-10,705 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$7.64 - $27.5 $81,786 - $294,387	10,705 New	10,705 $146,000
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $119,917 - $212,121	-12,950 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$7.54 - $18.31 $1.18 Million - $2.86 Million	-156,035 Reduced 92.34%	12,950 $217,000
Q2 2018 Aug 13, 2018	BUY	$4.87 - $8.42 $183,355 - $317,013	37,650 Added 28.67%	168,985 $1.24 Million
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $367,986 - $788,543	78,462 Added 148.4%	131,335 $616,000
Q4 2017 Feb 14, 2018	SELL	$7.86 - $9.99 $70,740 - $89,910	-9,000 Reduced 14.55%	52,873 $480,000
Q3 2017 Nov 13, 2017	BUY	$8.89 - $10.4 $550,050 - $643,479	61,873	61,873 $580,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.